Advanced search
Publication Cover
Hematology Volume 26, 2021 - Issue 1
Submit an article Journal homepage
2,855
Views
3
CrossRef citations to date
0
Altmetric
Case Report

T cell ALL in a child with Ataxia telangiectasia; diagnosis and management challenges

Omaima Ahmeda Pediatric Hematology Oncology department, Princess Nora Oncology center, King Abdul-Aziz Medical city, Jeddah, Saudi ArabiaCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-2706-7921
ORCID Icon,
Yara Felimbanb Pediatric department, Maternity and Children Hospital, Dammam, Saudi Arabia
&
Abeer Almehdarc Radiology department, King Abdul-Aziz Medical city, Jeddah, Saudi Arabia
Pages 348-354 | Published online: 10 Apr 2021

References

  • Taylor M. Ataxia-telangiectasia in children, guidance on diagnosis and clinical care. Nottingham University Hospitals. The Ataxia-Telangiectasia Society; 2014.
  • Crawford TO, Skolasky RL, Fernandez R, et al. Survival probability in ataxia telangiectasia 2006 Archives of Disease in Childhood.
  • Szczepanski T, Mahlaoui N, Loeffen JL. Treatment of acute leukemia in children with ataxia telangiectasia/M.H.D. Schoenaker et al. Eur J Med Genet. 2016;59:641e646.
  • Thomas A, Waldmann K. Robert Mcintire, serum-alpha-fetoprotein levels in patients with ataxia-telangiectasia Metabolism Branch and Laboratory of Cell Biology. Bethesda, Maryland 20014, U.S.A., the lancet Nov 25: National Cancer Institute; 1972.
  • Jastaniah W, Elimam N, Abdalla K, et al. Felimban s early vs. late MRD response- and risk-based treatment intensification of childhood acute lymphoblastic leukemia: a prospective pilot study from Saudi Arabia. Exp Hematol Oncol. 2018 Nov 19;7:29, doi:https://doi.org/10.1186/s40164-018-0121-x. . e Collection 2018.PMID:30479872.
  • Taylor AM, Metcalfe JA, Thick J. Leukemia and lymphoma in ataxia telangiectasia. Blood. 1996;87:423–438.
  • Suarez F, Mahlaoui N, Canioni D, et al. Incidence, presentation, and prognosis of malignancies in ataxia-telangiectasia: a report from the French national registry of primary immune deficiencies. J Clin Oncol. 2015;33–2(10):202e208.
  • Gatti R. Ataxia-telangiectasia. In: Pagon RA, Adam MP, Ardinger HH, Wallace SE, Amemiya A, Bean LJH, Bird TD, Dolan CR, Fong CT, Smith RJH, Stephens K, editors. Genereviews® [internet]. Seattle, WA: University of Washington; 1993-2016.
  • Yanofsky RA, Seshia SS, Dawson AJ, et al. Ataxia-telangiectasia: atypical presentation and toxicity of cancer treatment. Can J Neurol Sci. 2009;36(4):462e467.
  • Cohen JM, Cuckow P, Davies EG. Bladder wall telangiectasia causing life-threatening hematuria in ataxia-telangiectasia: a new observation. ActaPaediatr. 2008 May;97(5):667e669.
  • Pietrucha1 B, Heropolitañska-Pliszka E, Gatt RA, et al. Ataxia-Telangiectasia: guidelines for diagnosis and comprehensive care. Los Angeles: The David Geffen School of Medicine at UCLA; 2007.
  • Sandoval C, Swift M. Treatment of lymphoid malignancies in patients with ataxia-telangiectasia. Med Pediatr Oncol. 1998 Dec;31(6):491e497.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.